Darin Falk

Company: Lacerta Therapeutics, Inc.

Job title: Chief Scientific Officer

Seminars:

Exploring the Optimal Way to Measure & Monitor AAV Safety Signals in the CNS 9:30 am

• Assessing the accuracy of imaging technology to inform on the AAV safety profile • Identifying novel strategies to facilitate monitoring by using biomarkers • Investigating CNS gene therapy deliver method to minimize safety eventsRead more

day: Day Two

Panel Discussion: Understanding the Pitfalls Associated with Monkey Models 1:30 pm

• Assessing the mechanism for how monkeys manifest toxicity in response to AAV vectors • Elucidating the mechanism for how liver damage occurs in monkeys • Exploring the differences between the monkey and human cellular immune response to better inform AAV safety understandingRead more

day: Day One